The Vanguard Group, Inc. recently announced the acquisition of new stake in Senseonics Holdings Inc (AMEX:SENS). The institutional investor has increased its shareholding in the Healthcare company by 0.83% to 22.06 million shares with purchase of 0.18 million shares. This fresh investment now brings its stake to 4.18% valued currently at $13.01 million. In addition, BlackRock Fund Advisors raised its holdings by 1.31 million to 11.5 million shares. And Geode Capital Management LLC has lifted its position by 3.68% or 0.18 million shares – to 4.93 million shares.
With over 4.05 million Senseonics Holdings Inc (SENS) shares trading Tuesday and a closing price of $0.59 on the day, the dollar volume was approximately $2.39 million. The shares have shown a negative half year performance of -16.31% and its price on 12/26/23 lost nearly -2.43%. Currently, there are 479.64M common shares owned by the public and among those 464.96M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 5 analysts who have offered their price forecasts for SENS have a consensus price objective of $1.63. The analysts have set the share’s price value over the next 12 months at a high of $2.50 and a low of $0.40. The average price target is 63.8% above its recent price level and a downside to the estimated low will see the stock lose -47.5% over that period. But an upside of 76.4% will see the stock hit the forecast high price target while median target price for the stock is $2.00.
Insiders at the company have transacted a total of 45 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 29 of these insider trades were purchases, accounting for 8,310,563 shares. Insider sales of the common stock occurred on 16 occasions, with total insider shares sold totaling 2,704,912 shares.
The top 3 mutual fund holders in Senseonics Holdings Inc are Vanguard Total Stock Market ETF, Vanguard Extended Market Index Fu, and iShares US Medical Devices ETF. Vanguard Total Stock Market ETF owns 12.95 million shares of the company’s stock, all valued at over $7.64 million. iShares US Medical Devices ETF now owns shares totaling to 0.61% of the shares outstanding.
However, the script later moved the day high at 0.6047, down -2.43%. The company’s stock has a 5-day price change of -9.23% and 9.26% over the past three months. SENS shares are trading -42.72% year to date (YTD), with the 12-month market performance down to -44.34% lower. It has a 12-month low price of $0.46 and touched a high of $1.27 over the same period. SENS has an average intraday trading volume of 2.24 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -6.23%, 2.86%, and -10.86% respectively.
Institutional ownership of Senseonics Holdings Inc (AMEX: SENS) shares accounts for 13.24% of the company’s 479.64M shares outstanding. Mutual fund holders own 6.53%, while other institutional holders and individual stakeholders account for 6.72% and 12.40% respectively.
It has a market capitalization of $311.69M and a beta (3y monthly) value of 0.84. The earnings-per-share (ttm) stands at -$0.09. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.14% over the week and 7.27% over the month.
Analysts forecast that Senseonics Holdings Inc (SENS) will achieve an EPS of -$0.04 for the current quarter, -$0.04 for the next quarter and -$0.15 for 2024. The lowest estimate earnings-per-share for the quarter is -$0.05 while analysts give the company a high EPS estimate of -$0.04. Comparatively, EPS for the current quarter was $0.02 a year ago. Earnings per share for the fiscal year are expected to increase by 10.62%, and -6.01% over the next financial year. EPS should grow at an annualized rate of 32.10% over the next five years, compared to 26.61% over the past 5-year period.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 5 brokerage firm advisors rate Senseonics Holdings Inc (SENS) as a “Hold” at a consensus score of 3.00. Specifically, 2 Wall Street analysts polled rate the stock as a buy, while 1 of the 5 advise that investors “hold,” and 2 rated it as a “Sell.”
Looking at the support for the SENS, a number of firms have released research notes about the stock. Jefferies stated their Underperform rating for the stock in a research note on July 19, 2023, with the firm’s price target at $0.50.
